Viga Gemilang enterprise was established in 2019 and later incorporated as Viga Gemilang Diagnostics Sdn Bhd in Malaysia with the mission of developing and commercializing innovative Point of Care (POC) tests for tropical infectious diseases critical to Malaysia and Asia. Our goal is to create POC diagnostic solutions for areas with significant unmet needs globally.
Our current focus is on developing a locally produced Point of Care test for COVID-19, while also establishing a local manufacturing site for both infectious and non-infectious diseases. This initiative is not only essential for creating a valuable company by offering a broader range of products, but also for improving the quality of healthcare in Malaysia.